Synergy CHC Q1 2025 EPS up 30% YoY to $0.10; revenue down 13% to $8.2M

Synergy CHC Corp.

2025-Q1 EPS reported $0.10 revenue$8,170,534

Net income $876.3K, up 51% YoY; diluted EPS $0.10 vs $0.08; ninth consecutive profitable quarter.
Revenue $8.2M, down 13% from $9.4M; decline due to non-repeat of new product sell-in to one customer.
Gross margin improved to 75.4% from 72.0% on favorable product mix; operating expenses down 15%.
EBITDA $1.98M (margin 24.1%) vs $1.85M (19.7%) YoY; cash used in ops improved to $822.8K from $858K.
Debt refinancing term sheets signed to extend maturity to 2029; expects to accelerate free cash flow and close soon.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.